News & Events

BD Medical, a segment of BD (Becton, Dickinson and Company), announced today that GlaxoSmithKline (GSK) is using the BD Hypak SCF™ prefillable syringe system for their recently approved prefilled flu vaccine offering available in the US.

“We were proud to be associated with GSK on this effort, and we congratulate them on the FDA approval of their prefilled flu vaccine offering,” said Linda Tharby, Vice President and General Manager US, BD Medical – Pharmaceutical Systems. “For more than half a century, the BD Hypak™ prefill platform has been at the forefront in helping to provide our pharmaceutical partners real solutions in optimizing vaccine supply to meet the growing public need for vaccines and innovative solutions for some of the world’s leading public health concerns.”

BD Hypak™ prefill’s newest innovation, the BD Hypak™ PRTC glass prefillable syringe, will be used by GSK for their new prefilled flu vaccine offering. It is the first prefilled flu vaccine for people aged 18 to 64 offered exclusively in prefilled syringes, which GSK markets under the brand name Tip-Lok®.

The BD Hypak™ PRTC prefilled syringe technology features a specially designed plastic tip cap with familiar twist-off mechanism preferred by healthcare professionals. Additionally, BD Hypak™ prefills require minimal overfill over the desired dose and minimize medication errors; as a result, they contribute reductions in the cost of care and drug deliveries.

Features of this latest BD Hypak™ SCF advancement include:

• Innovative tip cap design that facilitates aseptic technique during tip cap removal
• Securely attached tip cap for optimum integrity of syringe tip and contents
• Easy and convenient-to-open tip cap
• Transparent BD Luer-Lok™ adaptor for visual inspection of the needle hub connection compatible with conventional and safety-engineered needles

BD has been a leader in the prefill industry for nearly 40 years and is an established drug delivery systems manufacturer for prefillable products worldwide. In 1954, BD produced the first disposable syringe and needle based on the BD Hypak platform.

Information about BD Hypak™ SCF:

In the US, BD Hypak™ SCF is the medication delivery system selected and used for prefilled flu vaccine and remains the preferred medication delivery system by pharmaceutical companies for vaccines and therapeutic drugs.

About BD

BD, a leading global medical technology company that makes and sells medical devices, instrumented systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs more than 25,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry, and the general public. For more information, please visit www.bd.com.